Lotus Eye Hospital & Institute Ltd: Intrinsic Value & Share Price Analysis

Q: What is the current share price and 52-week range of Lotus Eye Hospital & Institute Ltd?

Lotus Eye Hospital & Institute Ltd is trading at 120.00 as of 26 April 2026, with a FY2026-2027 high of 148 and low of 67.7. The stock is currently in the middle of its 52-week range. Market cap stands at 250 Cr..

Q: Is Lotus Eye Hospital & Institute Ltd financially healthy?

Key indicators: ROCE of 2.99 % is on the lower side. Dividend yield is 0.00 %.

Fair Value

₹111.92Fairly Valued by 6.73%vs CMP ₹120.00

P/E (385.0) × ROE (1.2%) × BV (₹29.20) × DY (2.00%)

₹27.12Overvalued by 77.40%vs CMP ₹120.00

MoS: -342.5% (Negative)Confidence: 70/100 (High)Models: All 10: Overvalued

Model	Category	Value	Weight	Signal
PE-ROE	Earnings	₹82.43	21%	Over (-31.3%)
Graham Number	Earnings	₹14.27	15%	Over (-88.1%)
Earnings Power	Earnings	₹8.67	10%	Over (-92.8%)
DCF	Cash Flow	₹0.77	13%	Over (-99.4%)
Net Asset Value	Assets	₹29.10	7%	Over (-75.8%)
EV/EBITDA	Enterprise	₹29.23	8%	Over (-75.6%)
Dividend Discount	Dividends	₹5.10	8%	Over (-95.8%)
Earnings Yield	Earnings	₹3.10	7%	Over (-97.4%)
ROCE Capital	Returns	₹9.66	7%	Over (-92%)
Revenue Multiple	Revenue	₹23.78	5%	Over (-80.2%)
Consensus (10 models)		₹27.12	100%	Overvalued

Key Drivers: EPS CAGR -26.3% drags value — could be higher if earnings stabilize. | P/E of 385 makes PE-ROE unreliable — asset/earnings models are better benchmarks.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -26.3%

*Investments are subject to market risks

Analyst Summary

Lotus Eye Hospital & Institute Ltd operates in the Hospitals & Medical Services segment, NSE: LOTUSEYE | BSE: 532998, current market price is ₹120.00, market cap is 250 Cr.. At a glance, stock P/E is 385, ROE is 1.22 %, ROCE is 2.99 %, book value is 29.2, dividend yield is 0.00 %. The latest intrinsic value estimate is ₹27.12, around 77.4% below the current price, so expectations may already be running ahead of this modelled fair value. On operating trend, latest reported sales are about ₹50 Cr versus the prior period change of 2.8%, while latest net profit is about ₹1 Cr with a prior-period change of -74.6%. The 52-week range shown on this page is 148/67.7, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisLotus Eye Hospital and Institute Ltd. is a Public Limited Listed company incorporated on 14/03/1997 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification…

This summary is generated from the stock page data available for Lotus Eye Hospital & Institute Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

Lotus Eye Hospital & Institute Ltd scores 56/100 (Average)

Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison

Stock Health62/100 · Moderate

ROCE 3.0% WeakROE 1.2% WeakD/E 0.00 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent

Smart Money60/100 · Moderate

FII holding up 0.01% (6mo) Slight increasePromoter holding at 40.7% Stable

Earnings Quality50/100 · Moderate

OPM contracting (16% → 10%) DecliningWorking capital: 0 days (improving) Efficient

Quarterly Momentum80/100 · Strong

Revenue (4Q): +5% YoY GrowingProfit (4Q): +30% YoY Strong

Industry Rank20/100 · Weak

P/E 385.0 vs industry 117.7 Premium to peersROCE 3.0% vs industry 10.6% Below peersROE 1.2% vs industry 10.7% Below peers3Y sales CAGR: 8% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 25, 2026, 11:04 pm

Market Cap	250 Cr.
Current Price	120
Intrinsic Value	₹27.12
High / Low	148/67.7
Stock P/E	385
Book Value	29.2
Dividend Yield	0.00 %
ROCE	2.99 %
ROE	1.22 %
Face Value	10.0
PEG Ratio	-14.61

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Lotus Eye Hospital & Institute Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Lotus Eye Hospital & Institute Ltd	250 Cr.	120	148/67.7	385	29.2	0.00 %	2.99 %	1.22 %	10.0
Asarfi Hospital Ltd	410 Cr.	208	236/85.0	24.4	45.2	0.00 %	15.8 %	14.1 %	10.0
Narayana Hrudayalaya Ltd	36,137 Cr.	1,768	2,372/1,564	43.8	199	0.25 %	20.8 %	24.2 %	10.0
Dr Lalchandani Labs Ltd	8.33 Cr.	9.61	21.2/8.15	17.7	11.7	0.00 %	2.81 %	3.08 %	10.0
Industry Average	12,265.67 Cr	526.40		117.73	71.28	0.06%	10.60%	10.65%	10.00

All Competitor Stocks of Lotus Eye Hospital & Institute Ltd

Quarterly Result

Metric	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	12.14	11.17	12.57	12.73	12.03	10.88	12.89	12.91	12.25	11.51	13.52	13.04	13.55
Expenses	10.03	9.78	10.18	10.92	10.45	10.12	11.23	11.76	11.46	11.68	12.04	12.27	12.89
Operating Profit	2.11	1.39	2.39	1.81	1.58	0.76	1.66	1.15	0.79	-0.17	1.48	0.77	0.66
OPM %	17.38%	12.44%	19.01%	14.22%	13.13%	6.99%	12.88%	8.91%	6.45%	-1.48%	10.95%	5.90%	4.87%
Other Income	0.32	0.36	0.29	0.28	0.34	0.40	0.31	0.27	0.22	0.52	0.19	0.27	0.24
Interest	0.02	0.02	0.02	0.01	0.04	0.03	0.06	0.08	0.13	0.09	0.12	0.12	0.29
Depreciation	0.77	0.78	0.73	0.89	0.98	1.12	1.06	1.23	1.31	-0.58	0.82	0.85	0.98
Profit before tax	1.64	0.95	1.93	1.19	0.90	0.01	0.85	0.11	-0.43	0.84	0.73	0.07	-0.37
Tax %	29.88%	31.58%	27.98%	28.57%	26.67%	-200.00%	28.24%	9.09%	-44.19%	70.24%	24.66%	-71.43%	-29.73%
Net Profit	1.16	0.65	1.38	0.85	0.66	0.02	0.62	0.10	-0.24	0.25	0.54	0.12	-0.26
EPS in Rs	0.56	0.31	0.66	0.41	0.32	0.01	0.30	0.05	-0.12	0.12	0.26	0.06	-0.13

Last Updated: March 4, 2026, 1:16 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 24, 2026, 9:16 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	28.69	29.90	31.13	33.96	38.02	38.43	40.55	32.35	38.90	47.03	48.20	49.55	51.62
Expenses	25.40	27.72	27.14	30.63	33.68	35.21	36.57	28.73	32.98	39.35	41.57	45.99	48.88
Operating Profit	3.29	2.18	3.99	3.33	4.34	3.22	3.98	3.62	5.92	7.68	6.63	3.56	2.74
OPM %	11.47%	7.29%	12.82%	9.81%	11.42%	8.38%	9.82%	11.19%	15.22%	16.33%	13.76%	7.18%	5.31%
Other Income	0.39	0.46	0.58	0.68	0.91	0.68	0.21	0.84	0.88	1.15	1.31	1.31	1.22
Interest	0.04	0.10	0.16	0.15	0.18	0.21	0.24	0.14	0.21	0.20	0.20	0.48	0.62
Depreciation	3.54	4.76	4.44	3.44	3.37	3.06	2.50	2.33	2.50	2.98	3.73	3.01	2.07
Profit before tax	0.10	-2.22	-0.03	0.42	1.70	0.63	1.45	1.99	4.09	5.65	4.01	1.38	1.27
Tax %	60.00%	-10.81%	-400.00%	-7.14%	-2.35%	-12.70%	26.90%	21.11%	27.14%	27.79%	27.43%	46.38%
Net Profit	0.04	-1.98	0.10	0.44	1.75	0.71	1.06	1.57	2.98	4.08	2.91	0.74	0.65
EPS in Rs	0.02	-0.95	0.05	0.21	0.84	0.34	0.51	0.75	1.43	1.96	1.40	0.36	0.31
Dividend Payout %	0.00%	0.00%	0.00%	236.36%	59.43%	0.00%	0.00%	66.24%	34.90%	25.49%	0.00%	0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	-5050.00%	105.05%	340.00%	297.73%	-59.43%	49.30%	48.11%	89.81%	36.91%	-28.68%	-74.57%
Change in YoY Net Profit Growth (%)	0.00%	5155.05%	234.95%	-42.27%	-357.16%	108.72%	-1.18%	41.70%	-52.90%	-65.59%	-45.89%

Lotus Eye Hospital & Institute Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	5%
5 Years:	4%
3 Years:	8%
TTM:	3%

Compounded Profit Growth
10 Years:	9%
5 Years:	-13%
3 Years:	-38%
TTM:	-70%

Stock Price CAGR
10 Years:	26%
5 Years:	33%
3 Years:	25%
1 Year:	61%

Return on Equity
10 Years:	3%
5 Years:	4%
3 Years:	4%
Last Year:	1%

Last Updated: September 5, 2025, 9:50 am

Balance Sheet

Last Updated: December 4, 2025, 1:34 am

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80
Reserves	30.57	28.59	28.69	29.26	29.84	29.32	30.46	31.90	33.81	36.78	38.61	39.20	39.82
Borrowings	0.18	0.83	0.66	0.48	0.29	0.22	0.32	0.40	1.24	0.67	1.11	3.43	4.80
Other Liabilities	7.01	6.20	4.68	4.40	7.28	6.18	6.53	6.12	5.75	4.93	6.11	6.14	6.09
Total Liabilities	58.56	56.42	54.83	54.94	58.21	56.52	58.11	59.22	61.60	63.18	66.63	69.57	71.51
Fixed Assets	46.94	47.04	43.57	41.32	42.52	44.14	42.67	40.54	44.07	44.18	48.65	54.07	55.17
CWIP	0.36	0.27	0.42	0.65	0.29	0.29	0.00	0.00	0.00	0.00	0.08	0.00	0.06
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	11.26	9.11	10.84	12.97	15.40	12.09	15.44	18.68	17.53	19.00	17.90	15.50	16.28
Total Assets	58.56	56.42	54.83	54.94	58.21	56.52	58.11	59.22	61.60	63.18	66.63	69.57	71.51

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	4.41	2.37	3.38	2.97	5.78	4.20	4.97	2.73	4.41	4.39	5.68	2.70
Cash from Investing Activity +	-5.05	-4.65	-0.85	-1.06	-3.86	-4.01	-0.68	0.49	-3.94	-2.19	-4.63	-6.13
Cash from Financing Activity +	-0.77	1.87	-0.58	-0.25	-1.51	-1.41	0.13	-0.32	-1.58	-1.71	-3.40	-1.60
Net Cash Flow	-1.41	-0.40	1.96	1.66	0.41	-1.22	4.42	2.90	-1.10	0.49	-2.35	-5.03
Free Cash Flow	-0.91	-2.38	2.28	1.55	1.58	-0.49	3.54	2.61	-0.25	1.30	0.10	-2.09
CFO/OP	135%	109%	85%	92%	142%	134%	132%	84%	89%	76%	101%	94%

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	3.11	1.35	3.33	2.85	4.05	3.00	3.66	3.22	4.68	7.01	5.52	0.13

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	4.96	4.27	5.98	7.31	10.94	7.22	5.94	8.35	5.82	9.08	9.54	9.72
Inventory Days	166.70	121.54	113.25	60.22	79.23	128.20	124.42	138.82	150.03	153.60	170.30	193.62
Days Payable	130.52	125.08	105.51	87.32	129.95	167.37	170.41	220.72	231.21	173.42	183.56	169.86
Cash Conversion Cycle	41.14	0.73	13.72	-19.79	-39.78	-31.95	-40.05	-73.54	-75.37	-10.74	-3.72	33.48
Working Capital Days	-13.10	-19.90	-8.56	-8.92	-26.02	-15.39	-21.33	-23.92	-16.33	8.61	4.85	0.00
ROCE %	0.27%	-4.23%	0.24%	1.19%	3.63%	1.66%	4.67%	3.92%	7.91%	10.25%	7.07%	2.99%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	58.17%	58.44%	57.58%	56.58%	41.40%	40.24%	40.03%	40.14%	40.22%	40.39%	40.63%	40.66%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%	0.01%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%	0.04%	0.02%	0.02%	0.02%
Public	41.83%	41.56%	42.43%	43.42%	58.60%	59.76%	59.97%	59.82%	59.73%	59.57%	59.33%	59.31%
No. of Shareholders	7,345	7,425	7,660	8,314	12,502	11,759	12,514	11,734	11,508	11,121	10,777	10,240

Shareholding Pattern Chart

No. of Shareholders

Lotus Eye Hospital & Institute Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	0.36	1.40	1.96	1.44	0.75
Diluted EPS (Rs.)	0.36	1.40	1.96	1.44	0.75
Cash EPS (Rs.)	1.80	3.19	3.39	2.64	1.87
Book Value[Excl.RevalReserv]/Share (Rs.)	28.85	28.57	27.69	26.26	25.34
Book Value[Incl.RevalReserv]/Share (Rs.)	28.85	28.57	27.69	26.26	25.34
Dividend / Share (Rs.)	0.00	0.50	0.50	0.50	0.50
Revenue From Operations / Share (Rs.)	23.83	23.18	22.62	18.71	15.56
PBDIT / Share (Rs.)	2.28	3.77	4.20	3.24	2.07
PBIT / Share (Rs.)	0.83	1.97	2.77	2.03	0.95
PBT / Share (Rs.)	0.66	1.93	2.72	1.97	0.95
Net Profit / Share (Rs.)	0.35	1.40	1.96	1.44	0.75
PBDIT Margin (%)	9.55	16.24	18.56	17.30	13.30
PBIT Margin (%)	3.48	8.51	12.22	10.87	6.10
PBT Margin (%)	2.78	8.32	12.01	10.52	6.15
Net Profit Margin (%)	1.49	6.04	8.66	7.67	4.84
Return on Networth / Equity (%)	1.23	4.90	7.08	5.46	2.97
Return on Capital Employeed (%)	2.78	6.79	9.91	7.57	3.69
Return On Assets (%)	1.06	4.37	6.45	4.84	2.64
Asset Turnover Ratio (%)	0.72	0.74	0.75	0.64	0.55
Current Ratio (X)	1.56	2.25	2.83	2.24	2.34
Quick Ratio (X)	1.04	1.74	2.30	1.84	2.03
Inventory Turnover Ratio (X)	14.08	2.81	3.28	3.19	2.61
Dividend Payout Ratio (NP) (%)	0.00	35.67	0.00	0.00	0.00
Dividend Payout Ratio (CP) (%)	0.00	15.65	0.00	0.00	0.00
Earning Retention Ratio (%)	0.00	64.33	0.00	0.00	0.00
Cash Earning Retention Ratio (%)	0.00	84.35	0.00	0.00	0.00
Interest Coverage Ratio (X)	13.34	80.42	89.47	52.56	66.35
Interest Coverage Ratio (Post Tax) (X)	3.05	30.86	42.80	24.38	23.91
Enterprise Value (Cr.)	141.22	110.46	112.37	102.10	77.22
EV / Net Operating Revenue (X)	2.85	2.29	2.39	2.62	2.39
EV / EBITDA (X)	29.83	14.10	12.87	15.17	17.93
MarketCap / Net Operating Revenue (X)	2.93	2.44	2.57	2.85	2.69
Retention Ratios (%)	0.00	64.32	0.00	0.00	0.00
Price / BV (X)	2.42	1.98	2.10	2.03	1.65
Price / Net Operating Revenue (X)	2.93	2.44	2.57	2.85	2.69
EarningsYield	0.01	0.02	0.03	0.02	0.01

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Lotus Eye Hospital and Institute Ltd. is a Public Limited Listed company incorporated on 14/03/1997 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L85110TZ1997PLC007783 and registration number is 007783. Currently company belongs to the Industry of Hospitals & Medical Services. Company's Total Operating Revenue is Rs. 49.56 Cr. and Equity Capital is Rs. 20.80 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Hospitals & Medical Services	S.F No.770/12, Avinashi Road, Coimbatore Tamil Nadu 641014	Contact not found

Management
Name	Position Held
Dr. Kavetha Sundaramoorthy	Chairman
Ms. Sangeetha Sundaramoorthy	Managing Director
Dr. K S Ramalingam	WholeTime Director & CEO
Mr. Karthik Veeramani	Director
CA. Perumalsamy Mahendran	Director
Dr. S Natesan	Director

FAQ

What is the intrinsic value of Lotus Eye Hospital & Institute Ltd and is it undervalued?

As of 26 April 2026, Lotus Eye Hospital & Institute Ltd's intrinsic value is ₹27.12, which is 77.40% lower than the current market price of ₹120.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (1.22 %), book value (₹29.2), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Lotus Eye Hospital & Institute Ltd?

Lotus Eye Hospital & Institute Ltd is trading at ₹120.00 as of 26 April 2026, with a FY2026-2027 high of ₹148 and low of ₹67.7. The stock is currently in the middle of its 52-week range. Market cap stands at ₹250 Cr..

How does Lotus Eye Hospital & Institute Ltd's P/E ratio compare to its industry?

Lotus Eye Hospital & Institute Ltd has a P/E ratio of 385, which is above the industry average of 117.73. This significantly elevated P/E suggests the market expects strong future growth, or the stock may be overpriced relative to current earnings.

Is Lotus Eye Hospital & Institute Ltd financially healthy?

Key indicators for Lotus Eye Hospital & Institute Ltd: ROCE of 2.99 % is on the lower side compared to the industry average of 10.60%; ROE of 1.22 % is below ideal levels (industry average: 10.65%). Dividend yield is 0.00 %.

Is Lotus Eye Hospital & Institute Ltd profitable and how is the profit trend?

Lotus Eye Hospital & Institute Ltd reported a net profit of ₹1 Cr in Mar 2025 on revenue of ₹50 Cr. Compared to ₹3 Cr in Mar 2022, the net profit shows a declining trend.

Does Lotus Eye Hospital & Institute Ltd pay dividends?

Lotus Eye Hospital & Institute Ltd has a dividend yield of 0.00 % at the current price of ₹120.00. The company is currently not paying meaningful dividends.